Showing results (271-280 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|May 19, 2023
Pyroptotic MAITs link microbial translocation with severity of alcohol-associated liver diseaseLi-Ping Zhang, Hui-Fang Wang, Xing-Ran Zhai, et al.
Hepatology Communications|May 19, 2023
Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survivalBurcin Özdirik, Maria Scherf, Ana Brumercek, et al.
Hepatology Communications|May 23, 2023
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trialAlexey Surov, Maximilian Thormann, Mattes Hinnerichs, et al.
Hepatology Communications|August 23, 2022
Granulocyte colony-stimulating factor attenuates liver damage by M2 macrophage polarization and hepatocyte proliferation in alcoholic hepatitis in miceYeonhee Cho, Radhika Joshi, Patrick Lowe, et al.
Hepatology Communications|August 26, 2022
A missense mutation in the proprotein convertase gene furinb causes hepatic cystogenesis during liver development in zebrafishJillian L Ellis, Kimberley J Evason, Changwen Zhang, et al.
Hepatology Communications|September 17, 2021
The Detrimental Role of Regulatory T Cells in Nonalcoholic SteatohepatitisJanine Dywicki, Laura Elisa Buitrago-Molina, Fatih Noyan, et al.
Hepatology Communications|September 17, 2021
Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During EntecavirTetsuya Hosaka, Fumitaka Suzuki, Mariko Kobayashi, et al.
Hepatology Communications|September 17, 2021
COVID-19 Aftershocks on Alcohol-Associated Liver Disease: An Early Cross-Sectional Report From the U.S. EpicenterStephanie M Rutledge, Thomas D Schiano, Sander Florman, et al.
Hepatology Communications|February 22, 2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trialDavid Jones, Marco Carbone, Pietro Invernizzi, et al.
Hepatology Communications|March 17, 2023
Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiringYing Xia, Emma Andersson, Sumit K Anand, et al.
Pageof 179